Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1953 USD | -4.96% |
|
-5.01% | -79.76% |
Jun. 04 | Apollomics Announces Vebreltinib Data At the 2024 American Society of Clinical Oncology Annual Meeting | CI |
May. 08 | Apollomics, Inc. Appoints Robert Lin to the Board of Directors | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
APOLLOMICS, INC. | Bio Therapeutic Drugs | -4.96% | -5.01% | -79.76% | -96.24% | - | 21.43M | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- APLM Stock
- Charts Apollomics, Inc.
- Relative Strength Chart